Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03549000 |
Title | A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | GBR | ESP | CAN | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
H Lee Moffitt Cancer Center and Research Institute Inc | Tampa | Florida | 33612 | United States | Details | |
University of Texas MD Anderson Cancer Center MD Anderson PSC | Houston | Texas | 77030 | United States | Details | |
Novartis Investigative Site | Melbourne | Victoria | 3000 | Australia | Details | |
Novartis Investigative Site | Toronto | Ontario | M5G 1Z6 | Canada | Details | |
Novartis Investigative Site | Montreal | Quebec | H2W 1T8 | Canada | Details | |
Novartis Investigative Site | Chuo ku | Tokyo | 104 0045 | Japan | Details | |
Novartis Investigative Site | Singapore | 169610 | Singapore | Details | ||
Novartis Investigative Site | Valencia | Comunidad Valenciana | 46010 | Spain | Details | |
Novartis Investigative Site | Madrid | 28009 | Spain | Details | ||
Novartis Investigative Site | Sutton | Surrey | SM2 5PT | United Kingdom | Details |